Intraoperative_electron_beam_radiation_therapy_for_retroperitoneal_soft_tissue_sarcoma._From_December_1981_to_December_1989,_20_patients_with_primary_or_recurrent_retroperitoneal_sarcoma_received_4000_to_5000_cGy_of_external_beam_radiation_therapy_(EBRT)_in_conjunction_with_surgical_resection_and_intraoperative_radiation_therapy_(IORT)._Seventeen_of_20_patients_underwent_complete_(14_patients)_or_partial_(3_patients)_resection._Three_patients_had_shown_evidence_of_metastases_after_EBRT_by_the_time_of_surgery._The_4-year_actuarial_local_control_and_disease-free_survival_rates_of_the_17_patients_undergoing_resection_were_81%_and_64%,_respectively._Twelve_patients_received_IORT_at_the_time_of_resection_for_microscopic_disease_(10_patients)_or_gross_residual_sarcoma_(2_patients)._Of_the_ten_patients_receiving_IORT_for_microscopic_tumor,_one_patient_has_died_of_local_failure_and_peritoneal_sarcomatosis_and_two_patients_have_died_of_distant_metastases_only._The_remaining_seven_patients_are_disease-free._One_patient_treated_for_gross_residual_sarcoma_has_experienced_a_local_failure_1_year_after_IORT_and_is_without_disease_7_years_after_salvage_chemotherapy._The_other_patient_treated_for_gross_residual_sarcoma_has_died_of_local_failure._Five_patients_did_not_receive_IORT_at_the_time_of_resection_because_of_the_extensive_size_of_the_tumor_bed._Three_of_these_patients_are_disease-free_with_one_patient_alive_with_lung_metastases_and_one_patient_dying_of_hepatic_metastases._Aggressive_radiation_and_surgical_procedures_appear_to_provide_satisfactory_resectability_and_local_control_with_acceptable_tolerance.